BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31
BALCHEM CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$170.42−0.31 (-0.18%)
Close on Oct 19, 2026
- Market cap
- $5.49B
- P/E (TTM)
- 33.5
- Dividend yield
- 0.56%
Share price
+$22.83 (+15.47%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
BALCHEM CORP grew revenue 10.1% to $1.09B over the twelve months to Jun 30, 2026. Operating income rose 12.0% to $221.72M, moving the operating margin from 20.1% to 20.4%.
Revenue
$1.09B
+10.1% vs. a year earlier
Operating income
$221.72M
+12.0% vs. a year earlier
EPS, diluted
$5.09
+16.7% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.49B
- P/E ratio
- 33.5
- Price to sales
- 5.05
- Price to book
- 4.21
- Dividend yield
- 0.56%
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.09B
- Net income
- $164.41M
- EPS, diluted
- $5.09
- Book value per share
- $40.45
- Diluted shares
- 32M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.09B+10.1% YoY
Gross profit
$394.12M+11.7% YoY
Operating income
$221.72M+12.0% YoY
Net income
$164.41M+15.2% YoY
EPS, diluted
$5.09+16.7% YoY
Free cash flow
–
Reported periodTrailing twelve months